Unicycive Therapeutics, Inc.
NASDAQ:UNCY
0.7692 (USD) • At close June 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | -0.271 | 0 | 0 | 0.675 | 0 | 0.951 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.134 | 0 | 0 | 0.284 | 0.082 | 0.079 | 0.078 | 0.045 | 0.002 | 0.001 | 0.002 | 0.002 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | -0.284 | -0.353 | -0.079 | -0.078 | 0.63 | -0.002 | 0.95 | -0.002 | -0.002 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 1.303 | 0 | 0 | 0.933 | 0 | 0.999 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.171 | 5.288 | 3.045 | 4.868 | 6.813 | 4.233 | 3.372 | 2.267 | 3.03 | 3.84 | 4.803 | 1.86 | 1.933 | 1.361 | 3.776 | 0.493 | 0.45 | 0.382 | 0.304 | 0.182 | 0.148 | 0.376 | 0.188 | 0.116 | 0.116 |
| General & Administrative Expenses
| 5.818 | 3.973 | 3.206 | 2.533 | 2.391 | 2.08 | 2.566 | 2.055 | 1.847 | 1.485 | 1.702 | 1.776 | 1.604 | 1.391 | 0.939 | 0.286 | 0.281 | 0.335 | 0.322 | 0.154 | 0.194 | 0.325 | 0.293 | 0.275 | 0.275 |
| Selling & Marketing Expenses
| 0 | 0.284 | 0 | 0 | -0.284 | -0.082 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.818 | 3.973 | 3.206 | 2.533 | 2.107 | 1.998 | 2.566 | 2.055 | 1.847 | 1.485 | 1.702 | 1.776 | 1.604 | 1.391 | 0.939 | 0.286 | 0.281 | 0.335 | 0.322 | 0.154 | 0.194 | 0.325 | 0.293 | 0.275 | 0.275 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 7.989 | 9.261 | 6.251 | 7.401 | 8.92 | 6.231 | 5.938 | 4.322 | 4.877 | 5.325 | 6.505 | 3.636 | 3.537 | 2.752 | 4.715 | 0.779 | 0.731 | 0.717 | 0.626 | 0.336 | 0.342 | 0.701 | 0.544 | 0.391 | 0.391 |
| Operating Income
| -7.989 | -9.261 | -6.251 | -7.401 | -9.204 | -6.313 | -5.938 | -4.322 | -4.202 | -5.325 | -5.554 | -3.636 | -3.537 | -2.752 | -4.715 | -0.779 | -0.731 | -0.717 | -0.626 | -0.336 | -0.342 | -0.701 | -0.481 | -0.391 | -0.391 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 23.295 | 0 | 0 | -6.225 | 0 | -5.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 8.559 | -12.264 | 2.155 | 17.256 | -11.759 | -1.485 | 1.605 | 0.484 | -10.373 | -0.003 | -0.003 | 0 | 0 | 0 | -0.486 | -0.321 | -0.233 | -0.163 | -0.076 | -0.002 | -0.002 | -0.001 | -0.083 | -0.059 | -0.059 |
| Income Before Tax
| 0.57 | -21.525 | -4.096 | 9.855 | -20.963 | -7.798 | -4.405 | -3.838 | -14.575 | -5.328 | -5.557 | -3.636 | -3.537 | -2.752 | -5.201 | -1.1 | -0.964 | -0.88 | -0.702 | -0.338 | -0.344 | -0.702 | -0.564 | -0.45 | -0.45 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 28.775 | 0 | 0 | -21.593 | 0 | -5.843 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.241 | 0 | 0 | 0.241 | -10.53 | -0.079 | 0.032 | 10.577 | 0.003 | 0.003 | 0.038 | 0.037 | -0.412 | 0.431 | -0.779 | -0.019 | -0.717 | -0.626 | -0.336 | -0.342 | -0.001 | -0.083 | -0.059 | -0.059 |
| Net Income
| 0.57 | -21.525 | -4.096 | 9.855 | -20.963 | -7.798 | -4.405 | -3.838 | -25.152 | -5.331 | -5.56 | -3.636 | -3.537 | -2.752 | -5.201 | -1.1 | -0.964 | -0.88 | -0.702 | -0.338 | -0.344 | -0.702 | -0.564 | -0.45 | -0.45 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 28.775 | 0 | 0 | -37.262 | 0 | -5.846 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.05 | -0.032 | -0.046 | 0.08 | -0.6 | -0.22 | -0.13 | -0.25 | -1.65 | -0.35 | -0.37 | -0.24 | -0.24 | -0.19 | -0.37 | -0.079 | -0.068 | -0.061 | -0.083 | -0.04 | -0.041 | -0.084 | -0.069 | -0.057 | -0.057 |
| EPS Diluted
| -0.05 | -0.032 | -0.046 | -0.15 | -0.6 | -0.22 | -0.13 | -0.25 | -1.65 | -0.35 | -0.37 | -0.24 | -0.24 | -0.19 | -0.37 | -0.079 | -0.068 | -0.061 | -0.082 | -0.039 | -0.041 | -0.084 | -0.069 | -0.057 | -0.057 |
| EBITDA
| -7.989 | -21.371 | -3.958 | -7.401 | -20.659 | -7.697 | -4.236 | -3.728 | -14.518 | -5.323 | -5.553 | -3.634 | -3.535 | -2.751 | -4.715 | -0.779 | 0 | -0.717 | 0 | -0.336 | -0.342 | 0 | -0.063 | 0 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 28.402 | 0 | 0 | -21.508 | 0 | -5.839 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |